Biotechnology firm Enlivex Therapeutics has secured $21 million through a debt financing agreement to expand its holdings of tokens linked to the prediction market platform Rain (RAIN). The financing was provided by The Lind Partners, enabling the company to strengthen its digital asset treasury strategy.
The company confirmed it exercised an option to purchase 3 billion RAIN tokens at a 62% discount for $10 million, while extending its option to acquire an additional 272.1 billion tokens at the same discounted rate until December 2027. Executive chair Shai Novik stated that the funding supports ongoing execution of the firm’s prediction markets treasury plan.
Prediction Market Growth Drives Corporate Token Adoption
Although Enlivex primarily develops cell therapy treatments for knee osteoarthritis, the company is among several non-crypto firms adding digital assets to their balance sheets to attract investors and diversify financial strategies. The firm also approved a $20 million share buyback program, intended to enhance shareholder value alongside its token investments.
The Rain platform operates on the Arbitrum and includes a 2.5% transaction fee designed to buy back and burn RAIN tokens, supporting supply-demand balance. Industry data shows prediction market trading volumes surged more than 1,200%, reaching $23.3 billion between February 2025 and February 2026.
Market Performance and Competitive Landscape
Following the announcement, the RAIN token rose 7% to $0.009 before stabilizing near $0.0088, recording a modest 0.3% daily gain. Shares of Enlivex (ENVL) closed down 0.9% to $1.10 but climbed 4.5% in after-hours trading to $1.15.
The broader prediction market sector remains dominated by Kalshi and Polymarket, which together account for more than 80% of total trading volume, highlighting strong competition as new platforms seek market share.
Disclaimer
This content is for informational purposes only and does not constitute financial, investment, or legal advice. Cryptocurrency trading involves risk and may result in financial loss.